Find therapies in clinical trials near you – page 337

Study on the Effectiveness of JNJ-77242113 and Deucravacitinib for Treating Moderate to Severe Plaque Psoriasis in Adults

Study on the Effectiveness of JNJ-77242113 and Deucravacitinib for Treating Moderate to Severe Plaque Psoriasis in Adults

Study on ABCB5+ MSCs for Recessive Dystrophic and Junctional Epidermolysis Bullosa Patients

Study on ABCB5+ MSCs for Recessive Dystrophic and Junctional Epidermolysis Bullosa Patients

Study on Rocatinlimab for Adolescents Aged 12-17 with Moderate-to-Severe Atopic Dermatitis

Study on Rocatinlimab for Adolescents Aged 12-17 with Moderate-to-Severe Atopic Dermatitis

Study of LY3454738 for Treating Moderate-to-Severe Atopic Dermatitis in Adults

Study of LY3454738 for Treating Moderate-to-Severe Atopic Dermatitis in Adults

Study on the Effectiveness and Safety of PQ Birch for Patients with Seasonal Allergic Rhinitis or Rhinoconjunctivitis from Birch Pollen

Study on the Effectiveness and Safety of PQ Birch for Patients with Seasonal Allergic Rhinitis or Rhinoconjunctivitis from Birch Pollen

Safety and Tolerability of ETHY-001 Compared with Saline 0.9% in Adults with Thyroid Eye Disease

Safety and Tolerability of ETHY-001 Compared with Saline 0.9% in Adults with Thyroid Eye Disease

Efficacy and Safety of BI 1015550 in Adults with Fibrosing Interstitial Lung Disease at Risk of Disease Progression: A Randomized, Placebo‑Controlled Trial

Efficacy and safety of zenagamtide versus semaglutide in adults with type 2 diabetes inadequately controlled on metformin and/or SGLT2 inhibitors

Prevention of Left Ventricular Thrombosis in Patients with Acute Anterior Myocardial Infarction Using Fondaparinux plus Standard Drug Combination

Prevention of Left Ventricular Thrombosis in Patients with Acute Anterior Myocardial Infarction Using Fondaparinux plus Standard Drug Combination

A Phase II Randomized, Double‑Blind Study of RO7568282 for Safety and Efficacy in Early‑Stage Parkinson’s Disease Patients

A Phase II Randomized, Double‑Blind Study of RO7568282 for Safety and Efficacy in Early‑Stage Parkinson’s Disease Patients

Safety and Tolerability of Intrathecal CMP-002 in Participants with SYNGAP1-Related Disorder

Safety and efficacy of NFL-102 versus placebo for adults with tobacco dependence (Phase I/II)

Safety and efficacy of NFL-102 versus placebo for adults with tobacco dependence (Phase I/II)